
Denosumab 60 mg (Denub) Injection is a prescription medicine used to treat osteoporosis and reduce the risk of fractures in patients with weakened bones. It contains Denosumab, a monoclonal antibody that helps regulate the natural process of bone breakdown. It is commonly prescribed for postmenopausal women and other adults at increased risk of fractures due to bone loss.
| Generic Name | Denosumab |
| Manufacturer | Alkem Laboratories Ltd |
| Packing | Single use pre-filled syringe |
| Prescribed For | Osteoporosis and bone loss |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Denosumab works by targeting a protein called RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand), which plays an important role in bone breakdown. It binds to RANKL and prevents it from activating osteoclasts, the cells responsible for breaking down bone tissue. This reduces excessive bone loss, helps maintain bone density and improves bone strength over time.